Kiniksa has interacted with the U.S. Food and Drug Administration (FDA) and expects to initiate a Phase 2/3 clinical trial of KPL-387 in recurrent pericarditis in mid-2025, with Phase 2 data expected ...

Ever wonder how celebrities always seem red carpet ready? Melanie Speed of Flawless Med Spa shares some insight.

Post-stroke treatment with indole-based AHR ligands improved microglia-mediated antigen processing and co-stimulatory immune functions. The role of Ifi27l2a, an interferon-induced gene ...

New therapeutic 'cocktails' may provide long-lasting relief for treatment-resistant asthma and other immune system inflammatory diseases.

Two therapeutic "cocktails" could stop immune cells from overreacting to allergens, providing long-lasting asthma relief.

Current asthma treatments don't work in all patients, and they don't provide long-term relief from potentially deadly asthma ...

Certain demographics have something in common with the baby boomers — not the elasticity of their skin but the contents of their bank accounts.

A groundbreaking study in Nature Medicine reveals that GD2 CAR-T cell therapy can lead to long-term remission in children ...

A patient has achieved over 18 years of remission from neuroblastoma, a type of nerve cell cancer, following treatment with ...

"That's mainly because it didn't put them up by as much as those peers did, but also because fiscal policy is turning ...